News

Transforming $1000 Into Almost $11000: The CBIZ Growth Story

Transforming $1000 Into Almost $11000: The CBIZ Growth Story

Transforming Investments Over Time

CBIZ has demonstrated a remarkable performance in the stock market over the past 15 years, outpacing the market by an impressive 4.79% annually. This reflects an average annual return of 17.33%, making it an attractive option for investors.

The Impact of Compounding Returns

If an individual had invested $1000 in CBIZ stock 15 years ago, that initial investment would now be valued at approximately $10,994.89, based on the current stock price of $64.54. This substantial growth illustrates the power of compound interest and how early investments can yield significant returns over time.

Understanding CBIZ's Market Presence

Currently, CBIZ boasts a considerable market capitalization of $3.49 billion. This position not only reflects the company's extensive footprint in its industry but also positions it favorably for future growth opportunities. Investors looking for strong companies may find CBIZ a compelling option.

The Value of Long-Term Investing

The experience of investing in CBIZ highlights the importance of a long-term investment strategy. It’s essential for investors to recognize that short-term market fluctuations are often less significant than the overall growth potential of investments held for extended periods.

Investor Considerations

When considering investing in companies like CBIZ, potential investors should evaluate various aspects including market trends, financial health, and competitive advantages. A thorough analysis of these elements can guide investors in making informed decisions.

Diversifying Your Portfolio

Investors should also consider diversifying their portfolios to manage risk effectively. While CBIZ has shown impressive returns, spreading investments across different sectors can help stabilize returns during volatile market conditions.

Conclusion

Investing in CBIZ over the last 15 years has proven to be a lucrative choice for those who believed in its potential from the outset. The substantial growth of a $1000 investment to nearly $11,000 highlights the efficacy of choosing strong performing stocks as part of a long-term investing strategy.

Frequently Asked Questions

How has CBIZ performed over the last 15 years?

CBIZ has outperformed the market with an annual return of 17.33%, significantly benefiting long-term investors.

What would a $1000 investment in CBIZ be worth today?

A $1000 investment in CBIZ from 15 years ago would be valued at around $10,994.89 today.

What is CBIZ's current market capitalization?

CBIZ currently has a market capitalization of approximately $3.49 billion.

What are key factors to consider when investing in CBIZ?

Investors should consider market trends, financial health, and competitive positioning when evaluating CBIZ.

Why is long-term investing important?

Long-term investing allows individuals to benefit from compound returns and ride out market fluctuations, leading to potentially substantial gains.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Orbis Celebrates 20 Years of Eye Care in Macau

Updated Category News Views 2

Celebrating Two Decades of Eye Health Innovation Orbis, a name synonymous with eye care worldwide, has hit a remarkable milestone. Celebrating two decades of commitment to eye health in Macau, they've rolled out their Flying Eye Hospital with a mission of profound impact. This isn't just about a fancy airplane; it’s about real, lasting change through training projects...

Continue Reading
Ramaco Resources Faces Stock Shake-Up Amid Distribution

Updated Category News Views 0

Stock Shake-Up In The Coal Industry Something's brewing in the coal mines of West Virginia, and it isn't just the usual dust settling. Ramaco Resources, Inc. (NASDAQ: METC), the metallurgical coal titan, is feeling the heat from some unexpected stock market turbulence, and it's got everyone in the investment trenches scratching their heads. The Yorktown Energy Partners'...

Continue Reading
What to Expect from KeyCorp at Barclays Event

Updated Category News Views 4

KeyCorp's Next Move: An Insider's View Yep, circle that calendar, folks. Looks like KeyCorp's gonna be laying it all out there for the financial world to see. Clark Khayat, their numero uno money guy, is hitting the stage at the Barclays Global Financial Services Conference on Sept. 14. So grab the popcorn—or, more like, your portfolio tracker—because this could get...

Continue Reading
Charity's Bold Move: Acquiring Wayfinder for K-12 Impact

Updated Category News Views 1

Public Charity Expands Into Education Well, here's something that's bound to turn a few heads: a fast-growing public charity has just made its first acquisition in the K-12 sphere by snapping up Wayfinder. The stakes are getting interesting. When a charity starts playing in the acquisition space, you're looking at a change in strategy that deserves close attention. Why...

Continue Reading
YSL Beauty’s Block Party Series Rocks London's Scene

Updated Category News Views 3

YSL Beauty: More Than a Brand, a Cultural Movement London felt a distinct pulse this past weekend as YSL Beauty kicked off another sizzling event in its Block Party series. This one wasn't just another Instagrammable gathering; it was the kind of scene that shifted the cultural needle. What started in Madrid has now become a roving spectacle that sweeps across cities,...

Continue Reading
XTEND Launches on NYSE Amid Market Milestones

Updated Category News Views 2

XTEND Steps Into the NYSE Spotlight Out of the gate, let's talk about XTEND—a name that's about to make waves on the New York Stock Exchange. With their debut under the ticker XTND, these folks are slamming their flag into the financial terrain like a knight ready for battle. XTEND, an AI-powered defense robotics and software outfit, isn't just joining the party—it's...

Continue Reading
Argo Biopharma's BW-20805 Shows Promise in HAE Phase II Trial

Updated Category News Views 1

Argo's Gains in Hereditary Angioedema Therapy Think about it, folks – reducing a hereditary angioedema attack by over 80%? Argo Biopharma, the slick operator in the RNA therapeutics space, is flexing its muscles again. They've hauled in some impressive data for their siRNA therapeutic, BW-20805, at the 2026 Bradykinin Symposium in Berlin. For you deep-pocketed investors...

Continue Reading
Ed Markey's Political Future on Shaky Ground in MA

Updated Category News Views 2

Massachusetts Voters Voice Desire for Change Ever seen an old engine stutter and cough before finally quitting? That's what Ed Markey's political career is starting to feel like. A fresh poll has surfaced, casting doubt over his steady grip on his longstanding Senate seat in Massachusetts. People are yearning for fresh faces and new ideas like never before. It's as if the...

Continue Reading
Acepodia's ACE723 Clears FDA Hurdle for Hepatocellular Push

Updated Category News Views 4

Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...

Continue Reading
Parents Champion Meta's Online Safety Agreement

Updated Category News Views 3

Any old-timer in the market game will tell you this: safeguarding the next generation runs deeper than just chasing profits. A recent poll by the Coalition to Empower our Future reveals something that ain’t too surprising if you’ve been paying attention. Parents all over the nation are nodding along to Meta’s new move to bolster online protections for younger folks....

Continue Reading

Top 5 Most Recently Viewed Articles

Howmet Aerospace CEO to Speak at Esteemed Industrial Conference

Updated Category News Views 138

Howmet Aerospace CEO to Present at Industrial Conference Howmet Aerospace Inc. (NYSE: HWM) has exciting news as its Chairman and Chief Executive Officer, John C. Plant, is set to speak at a prestigious industrial conference hosted by Jefferies. This event, which showcases significant innovations and advancements in the aerospace sector, will take place soon, drawing...

Continue Reading
Join the Class Action Against Walgreens Boots Alliance Today!

Updated Category News Views 100

Join the Class Action Against Walgreens Boots Alliance Levi & Korsinsky, LLP, a prominent name in investor rights, is reaching out to investors of Walgreens Boots Alliance, Inc. (WBA) regarding a potential class action securities lawsuit. If you have been impacted by their alleged wrongdoings, now is the time to know your rights and how to claim them. Understanding the...

Continue Reading
Lazydays Sets Record Date for Exciting Rights Offering

Updated Category News Views 346

Lazydays Announces Record Date for Rights Offering Lazydays Holdings, Inc. (NasdaqCM: GORV) is gearing up for an exciting rights offering. The special independent committee of the Board of Directors has confirmed key details, including the record date for this initiative, which is vital for investors closely monitoring their options. Details of the Rights Offering The...

Continue Reading
Veterans Get a Unique Pass to 2026 Building Industry Show

Updated Category News Views 6

Veterans and the Building Industry: An Invitation Worth Considering U.S. military veterans, here's a chance to dive into a different kind of battlefield. The Building Industry Show (BIS) in Southern California is swinging open its doors for you, free of charge, on September 2-3, 2026. If you're someone who's worn the uniform and is now eyeing a new career path, this is...

Continue Reading
Tarter and Chute Help Unite for Innovative Ranching Solutions

Updated Category News Views 571

Transforming the Ranching Landscape Tarter Farm and Ranch Equipment, recognized as a leading manufacturer of livestock tools, is excited to announce its new partnership with Chute Help, Inc. This alliance is set to make significant waves in the Western ranching and rodeo equipment sectors. By combining Tarter's renowned manufacturing prowess with Chute Help's legacy of...

Continue Reading